Siemens Healthineers to Invest EUR 350 Million in New Campus Forchheim

Siemens HealthineersSiemens Healthineers is planning to expand its location in Forchheim in response to the continuing strong demand for medical imaging devices, in particular for CT scanners and x-ray applications. The new "Siemens Healthineers Campus" will consist of an ultra-modern factory for medical components and a new R&D and logistics center alongside the existing facilities. Siemens Healthineers will be investing around EUR 350 million in this project over the next five years. Construction at the site is scheduled to begin in 2020.

"With its IPO, Siemens Healthineers set itself the clear ambition to shape the future of healthcare. This forward-looking investment into the Forchheim campus is a critical milestone paying into this direction. It reinforces our claim to generate sustainable, profitable growth based on the strength of our market and technology leadership as well as demonstrating our commitment to our home market Germany," said Michael Sen, Supervisory Board Chairman of Siemens Healthineers.

"This is one of the biggest investments ever made by Siemens Healthineers. Construction of this ultra-modern campus in Forchheim demonstrates our commitment to meeting the strong demand for imaging technology and will help us secure our position as an innovation and market leader," stated Bernd Montag, CEO of Siemens Healthineers.

Production of x-ray tube assemblies and generators for x-ray machines is planned to begin in 2023. The new facilities will consist of 47,000 square meters, and the existing production for these components in Erlangen, with around 700 employees, will be relocated to Forchheim. The new state-of-the-art facility will make production less costly, enhance the quality of the products and provide adequate capacities for further growth.

The company currently has separate facilities for x-ray machines and generators in the neighboring city of Erlangen. Expansion of the production capacities at the existing locations is not possible due to a lack of space. Siemens Healthineers is therefore also expanding its Forchheim location by purchasing more land. The Forchheim city council already approved the preliminary planning application in October 2018. Buildings being vacated in Erlangen will be used for other purposes by Siemens Healthineers and Siemens AG in the future.

In addition to the production and administration buildings at the site, Siemens Healthineers plans to construct a test and development center at the Forchheim Campus. Construction of a car park for employees on the site is also planned. The pace of innovation and development and exploitation of synergy potential are to be accelerated and enhanced through the close interaction of the two production facilities and direct proximity to the business units. For example, CT scanners are to be built in Forchheim, thus shortening the supply channels for the x-ray tube assemblies and generators used in these products to a minimum in the future. Having the business units in the immediate vicinity will also improve coordination in the development and production of the equipment.

The headquarters of both the Diagnostic Imaging (DI) and Advanced Therapy (AT) business segments are currently located in Forchheim. The future Campus will consist of the existing production and administration buildings, along with the new development and production facilities for x-ray tube assemblies and generators.

X-ray tube assemblies and x-ray generators are medical components used in CT scanners, for example. The x-ray tube assemblies contain the x-ray tubes that generate the x-ray radiation. X-ray generators include all the components required for operation of the x-ray tubes. They also generate and regulate the high voltage required for operation of the x-ray tubes.

About Siemens Healthineers

Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services.

In fiscal 2018, which ended on September 30, 2018, Siemens Healthineers generated revenue of €13.4 billion and adjusted profit of €2.3 billion and has about 50,000 employees worldwide.

Most Popular Now

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Emotional Cognition Analysis Enables Nea…

A joint research team from the University of Canberra and Kuwait College of Science and Technology has achieved groundbreaking detection of Parkinson's disease with near-perfect accuracy, simply by analyzing brain...

New Recommendations to Increase Transpar…

Patients will be better able to benefit from innovations in medical artificial intelligence (AI) if a new set of internationally-agreed recommendations are followed. A new set of recommendations published in The...

Digital Health Unveils Draft Programme f…

18 - 19 March 2025, Birmingham, UK. Digital Health has unveiled the draft programme for its Rewired 2025 event which will take place at the NEC in Birmingham in March next...

AI System Helps Doctors Identify Patient…

A new study from Vanderbilt University Medical Center shows that clinical alerts driven by artificial intelligence (AI) can help doctors identify patients at risk for suicide, potentially improving prevention efforts...

Smartphone App can Help Reduce Opioid Us…

Patients with opioid use disorder can reduce their days of opioid use and stay in treatment longer when using a smartphone app as supportive therapy in combination with medication, a...

AI's New Move: Transforming Skin Ca…

Pioneering research has unveiled a powerful new tool in the fight against skin cancer, combining cutting-edge artificial intelligence (AI) with deep learning to enhance the precision of skin lesion classification...

Leveraging AI to Assist Clinicians with …

Physical examinations are important diagnostic tools that can reveal critical insights into a patient's health, but complex conditions may be overlooked if a clinician lacks specialized training in that area...

AI can Improve Ovarian Cancer Diagnoses

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images. The study is...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...